Delivery Order SPE2DR25D1100-SPE2DR26FCU8C
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,756.42 to AmerisourceBergen Drug Corp for the supply of Jardiance 10mg tablets (90-count) on November 18, 2025, with completion scheduled for December 16, 2025. This firm fixed-price, non-set-aside contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $4,892.01 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on December 11, 2025, with an ultimate completion date of December 12, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the contract...
- The Defense Logistics Agency awarded a delivery order valued at $11,275.03 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) with an ultimate completion date of August 11, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) under a firm fixed price contract valued at $9,799.56. The award, issued on December 4, 2025, with an ultimate completion date of December 5, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Jardiance 10 mg tablets in quantities of 90 units. This contract, valued at $9,013.99, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award to the pharmaceutical distributor. The order is scheduled for completion by November 18, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $88,546.39 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on November 12, 2025, with an ultimate completion date of November 13, 2025. This competitive award carries firm fixed-price pricing and involves no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,001.08 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on June 2, 2025, with an ultimate completion date of June 3, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription medication commonly used in diabetes management,...
- The Defense Logistics Agency awarded a delivery order valued at $31,291.67 to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Jardiance 10 mg tablets (90-count units). This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award based on open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 15, 2025. This delivery order is...
- The Defense Logistics Agency awarded a $17,911.04 delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed-price contract. The delivery order was competitively awarded without set-aside designation and carries an ultimate completion date of September 16, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,297.06 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on June 27, 2025, with completion scheduled for June 30, 2025. This firm fixed price, competitively awarded delivery order represents a pharmaceutical supply requirement without set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills the place of...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCU8CDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,967.99 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units), with an ultimate completion date of December 16, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to this qualified pharmaceutical vendor. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support to military healthcare programs, enabling the company to supply an extensive range of medications, vaccines, and medical supplies to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The diabetes medication Jardiance represents one of many therapeutic products delivered through this strategic pharmaceutical supply agreement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 12/14/25 |